HD-OPM Archive
Topics › Fasting & meal timing

Evidence mostly supports Ramadan fasting as safe, improving metabolic and CVD risk markers

Louis Nervegna · Sep 03, 2025 · ♥ 9 reactions · 1 comments · original Facebook post
Fasting & meal timingInsulin resistance & diabetes
AI summary & key facts

Louis argues that systematic reviews and meta-analyses show Ramadan fasting is generally safe and healthy, improving insulin resistance, metabolic syndrome markers and other CVD risk factors. He adds that this is unsurprising for calorie restriction in an overweight population.

There is a large body of medical literature on health benefits of fasting during Ramadan. The preponderance of evidence supports it as both safe and healthy. Many studies have shown that fasting during Ramadan improves markers of insulin resistance and metabolic syndrome, as well as other risk factors for CVD.

Most of the references cited below are systematic reviews and meta-analyses of the many studies on this topic of Ramadan fasting.

This is not surprising. Any intervention that restricts calories and reduces visceral fat in a predominantly overweight population is likely to have health benefits.

Quoted:

“The many health benefits of Ramadan diurnal intermittent fasting (RDIF) include improvements in body weight and body composition (4–6), reducing complications of the metabolic syndrome (4), improving lipid profiles and other cardiometabolic risk factors (7–10). Further, in healthy people, RDIF helps improve glucose homeostasis (11), ameliorate inflammatory and oxidative stress markers (10), improve liver function tests (3), and modulate gene expression of various components of the anti-inflammatory and antioxidant defense and circadian rhythm systems (12, 13). In subjects with metabolic syndrome, RDIF was shown to improve several components of metabolic syndrome, upregulate tumor-suppressor proteins and downregulate tumor-promoter proteins (14).”

References:

  1. Faris ME, Jahrami HA, Alsibai J, Obaideen AA. Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis. Br J Nutrition. (2020)
  1. Jahrami HA, Alsibai J, Clark CC, Faris ME. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above. Eur J Nutr. (2020)
  1. Fernando H, Zibellini J, Harris R, Seimon R, Sainsbury A. Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. (2019)
  1. Jahrami HA, Faris ME, Janahi A, Janahi M, Abdelrahim DN, Madkour MI, et al. Does four-week consecutive, dawn-to-sunset intermittent fasting during Ramadan affect cardiometabolic risk factors in healthy adults? A systematic review, meta-analysis, and meta-regression. Nutr Metabol Cardiovasc Dis. (2021)
  1. Dalah HAH. H., Radwan HA, Jahrami O, Hamdy, Mohammad MG. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals Diabetes Research and Clinical Practice. (2019)
  1. Faris M, Kacimi S, Refat A, Fararjeh MA, Bustanji YK, Mohammad MK, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. (2012)
  1. Faris ME, Jahrami HA, Obaideen AA, Madkour MI. Impact of diurnal intermittent fasting during Ramadan on inflammatory and oxidative stress markers in healthy people: systematic review and meta-analysis. J Nutr Intermed Metabol. (2019)
  1. Faris ME, Jahrami HA, BaHammam A, Kalaji Z, Madkour M, Hassanein M. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on glucometabolic markers in healthy subjects. Diabet Res Clin Practice. (2020)
  1. Madkour MI, El-Sherif AT, Jahrami HA, Sherif NM, Hassen RE, Awadallah S, et al. Ramadan diurnal intermittent fasting modulates SOD2, TFAM, Nrf2, and sirtuins (SIRT1, SIRT3) gene expressions in subjects with overweight and obesity. Diabet Res Clin Practice. (2019)
  1. Ajabnoor GM, Bahijri S, Shaik NA, Borai A, Alamoudi AA, Al-Aama JY, et al. Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors. PLoS ONE. (2017)
  1. Mindikoglu AL, Abdulsada MM, Jain A, Jalal PK, Devaraj S, Wilhelm ZR, et al. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. (2020)

#fastingHD #ramadanHD #insulinresistanceHD #metabolicsyndromeHD

Paper · Front Nutr · 2022Editorial: The model of Ramadan diurnal intermittent fasting: Unraveling the health implications - volume I.Secure .gov websites use HTTPS A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.pmc.ncbi.nlm.nih.gov

Research cited

← newer: Cocoa raised circulating stem cells 2.2-fold and endothelialolder: Vitamin C, NAC and glutathione can cause falsely high readin →